Drugs / GSK2321138A
GSK2321138A
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT01195779 | Sep 2010 → Mar 2011 | influenza | GlaxoSmithKline | Terminated | No outcome recorded |
| Phase 2 | NCT00985790 | Oct 2009 → May 2010 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 34 trials | ||||||
| Phase 3 | NCT01954251 | Oct 2013 → Jun 2014 | herpes zoster | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT01439360 | Oct 2011 → Oct 2014 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT01204671 | Oct 2010 → Jun 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT01196988 | Oct 2010 → Jun 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK2321138A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01439360 ↗ |
| Known as | Flu D-QIV | “Quadrivalent seasonal influenza vaccine(Flu D-QIV) GSK2321138A” NCT01439360 ↗ |
| Known as | Influsplit Tetra vaccine | “Subjects received 1 or 2 doses of candidate influenza Influsplit™ Tetra vaccine (GSK2321138A).” NCT01439360 ↗ |
| Modality | Vaccine | “GSK2321138A vaccine” NCT00985790 ↗ |
| Route | Intramuscular | “The GSK2321138A vaccine was administered intramuscularly in the deltoid of the right arm.” NCT00985790 ↗ |